Technology
Ceragon Reports 11.5% Increase in Quarterly Revenue, GAAP EPS of $0.09 Per Share in the Second Quarter
Published
5 months agoon
By
Significant Penetration into Private Networks
Management Reiterates Full-Year 2024 Outlook
ROSH HA‘AIN, Israel, Aug. 7, 2024 /PRNewswire/ — Ceragon (NASDAQ: CRNT), the leading solutions provider of end-to-end wireless connectivity, today reported its financial results for the second quarter period ended June 30, 2024.
Q2 2024 Financial Highlights:
Revenues of $96.1 millionOperating income of $10.4 million on a GAAP basis, or $13.1 million on a non-GAAP basisNet Income of $7.8 million on a GAAP basis, and net income of $9.9 million on a non-GAAP basisEPS of $0.09 per diluted share on a GAAP basis, or $0.11 per diluted share on a non-GAAP basis
Q2 2024 Business Highlights:
India:
– Record quarterly revenues since Q2 2018, including revenue from the new, top-tier customer
– Substantial ramp up in demand for new IP-50CX product, with more than 20,000 radio units deliveredNorth America:
– Bookings remain strong, supported by Private Network wins
– Significant Private Network orders, including nine new customers
– Six consecutive quarters of revenue above $20 million
Doron Arazi, CEO, commented: “Our stated strategy of diversifying our business by expanding our presence with private networks has been successful. We have added significant bookings from private networks, both in North America and in other key regions, meaningfully growing our business in our addressable market. Demand in India remains robust, and we are growing market share in the region. We also have seen increased interest in our software solutions that can enable recurring revenue growth. New products introduced in the last six months are facilitating our growth, with significant shipments and high levels of customer satisfaction. We are well-positioned for continued profitable growth.”
Primary Second Quarter 2024 Financial Results:
Revenues were $96.1 million, up 11.5% from $86.2 million in Q2 2023 and up 8.6% from $88.5 million in Q1 2024.
GAAP Operating income was $10.4 million compared with $5.7 million for Q2 2023 and $4.2 million for Q1 2024.
GAAP Net income was $7.8 million, or $0.09 per diluted share, compared with $2.1 million, or $0.02 per diluted share for Q2 2023 and $0.4 million, or $0.00 per diluted share for Q1 2024.
Non-GAAP results were as follows: Gross margin was 35.2%, operating profit was $13.1 million, and net income of $9.9 million, or $0.11 per diluted share. The second quarter included $4 million benefit related to an initial collection from a $12 million debt settlement agreement reached with a South American customer. Another installment was paid during Q3, and the remaining installment is expected to be paid subject to several conditions.
Balance Sheet
Cash and cash equivalents were $26.3 million on June 30, 2024, compared to $28.8 million on March 31, 2024.
For a reconciliation of GAAP to non-GAAP results, see the attached tables.
Revenue Breakout by Geography:
Q2 2024
India
37 %
North America
24 %
EMEA
20 %
Latin America
10 %
APAC
9 %
Outlook
Management reiterated its 2024 outlook:
Revenue of $385 million to $405 million, representing growth of 11% to 17% compared to 2023 revenue. This guidance includes the contribution from Siklu, which was acquired in December 2023.Non-GAAP operating margins are targeted to be at least 10% at the mid-point of the revenue guidance.As a result, management expects increased non-GAAP profit and positive free cash flow for the full year of 2024.
Conference Call
The Company will host a Zoom web conference today at 8:30 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Recent geopolitical events could impact the live question and answer session. In this unlikely event, management’s prepared remarks will be pre-recorded, and the question and answer session would be rescheduled.
Investors are invited to register by clicking here. All relevant information will be sent upon registration.
If you are unable to join the live call, a replay will be available on our website at www.ceragon.com within 24 hours after the call.
About Ceragon
Ceragon (NASDAQ: CRNT) is the global innovator and leading solutions provider of end-to-end wireless connectivity, specializing in transport, access, and AI-powered managed & professional services. Through our commitment to excellence, we empower customers to elevate operational efficiency and enrich the quality of experience for their end users.
Our customers include service providers, utilities, public safety organizations, government agencies, energy companies, and more, who rely on our wireless expertise and cutting-edge solutions for 5G & 4G broadband wireless connectivity, mission-critical services, and an array of applications that harness our ultra-high reliability and speed. Ceragon solutions are deployed by more than 600 service providers, as well as more than 1,600 private network owners, in more than 130 countries.
Through our innovative, end-to-end solutions, covering hardware, software, and managed & professional services, we enable our customers to embrace the future of wireless technology with confidence, shaping the next generation of connectivity and service delivery. Ceragon delivers extremely reliable, fast to deploy, high-capacity wireless solutions for a wide range of communication network use cases, optimized to lower TCO through minimal use of spectrum, power, real estate, and labor resources – driving simple, quick, and cost-effective network modernization and positioning Ceragon as a leading solutions provider for the “connectivity everywhere” era.
For more information please visit: www.ceragon.com
Ceragon Networks® and FibeAir® are registered trademarks of Ceragon Networks Ltd. in the United States and other countries. CERAGON® is a trademark of Ceragon, registered in various countries. Other names mentioned are owned by their respective holders.
Safe Harbor
This press release contains statements that constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs, expectations and assumptions of Ceragon’s management about Ceragon’s business, financial condition, results of operations, micro and macro market trends and other issues addressed or reflected therein. Examples of forward-looking statements include, but are not limited to, statements regarding: projections of demand, revenues, net income, gross margin, capital expenditures and liquidity, competitive pressures, order timing, supply chain and shipping, components availability; growth prospects, product development, financial resources, cost savings and other financial and market matters. You may identify these and other forward-looking statements by the use of words such as “may”, “plans”, “anticipates”, “believes”, “estimates”, “targets”, “expects”, “intends”, “potential” or the negative of such terms, or other comparable terminology, although not all forward-looking statements contain these identifying words.
Although we believe that the projections reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations therefrom will not be material. Such forward-looking statements involve known and unknown risks and uncertainties that may cause Ceragon’s future results or performance to differ materially from those anticipated, expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the effects of global economic trends, including recession, rising inflation, rising interest rates, commodity price increases and fluctuations, commodity shortages and exposure to economic slowdown; The effects of the evolving nature of the war situation in Israel and the related evolving regional conflicts; risks associated with delays in the transition to 5G technologies and in the 5G rollout; risks relating to the concentration of our business on a limited number of large mobile operators and the fact that the significant weight of their ordering, compared to the overall ordering by other customers, coupled with inconsistent ordering patterns, could negatively affect us; risks resulting from the volatility in our revenues, margins and working capital needs; disagreements with tax authorities regarding tax positions that we have taken could result in increased tax liabilities; the high volatility in the supply needs of our customers, which from time to time lead to delivery issues and may lead to us being unable to timely fulfil our customer commitments; and such other risks, uncertainties and other factors that could affect our results of operation, as further detailed in Ceragon’s most recent Annual Report on Form 20-F, as published on March 21, 2024, as well as other documents that may be subsequently filed by Ceragon from time to time with the Securities and Exchange Commission.
We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Ceragon does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless required by law.
While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Ceragon’s views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Ceragon does not assume any obligation to update any forward-looking statements unless required by law.
The results reported in this press-release are preliminary and unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.
Ceragon’s public filings are available on the Securities and Exchange Commission’s website at www.sec.gov and may also be obtained from Ceragon’s website at www.ceragon.com.
Ceragon Investor & Media Contact:
Rob Fink
FNK IR
Tel. 1+646-809-4048
crnt@fnkir.com
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S. dollars in thousands, except share and per share data)
(Unaudited)
Three months ended
June 30,
Six months ended
June 30,
2024
2023
2024
2023
Revenues
96,088
86,151
184,586
169,560
Cost of revenues
62,627
55,795
119,057
111,028
Gross profit
33,461
30,356
65,529
58,532
Operating expenses:
Research and development, net
8,385
7,812
17,232
15,750
Sales and Marketing
11,508
9,778
22,769
19,974
General and administrative
2,295
6,218
8,158
11,542
Restructuring and related charges
–
897
1,416
897
Acquisition- and integration-related charges
915
–
1,377
–
Total operating expenses
23,103
24,705
50,952
48,163
Operating income
10,358
5,651
14,577
10,369
Financial expenses and others, net
1,916
1,886
4,777
3,344
Income before taxes
8,442
3,765
9,800
7,025
Taxes on income
609
1,677
1,564
2,969
Net income
7,833
2,088
8,236
4,056
Basic net income per share
0.09
0.02
0.10
0.05
Diluted net income per share
0.09
0.02
0.09
0.05
Weighted average number of shares used in
computing basic net income per share
85,743,770
84,365,168
85,632,241
84,359,762
Weighted average number of shares used in
computing diluted net income per share
87,921,507
85,312,954
87,753,163
85,152,634
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands)
June 30,
December 31,
2024
2023
Unaudited
Audited
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
26,303
28,237
Trade receivables, net
112,895
104,321
Inventories
59,490
68,811
Other accounts receivable and prepaid expenses
17,601
16,571
Total current assets
216,289
217,940
NON-CURRENT ASSETS:
Severance pay and pension fund
4,807
4,985
Property and equipment, net
33,853
30,659
Operating lease right-of-use assets
17,817
18,837
Intangible assets, net
16,510
16,401
Goodwill
7,749
7,749
Other non-current assets
2,010
1,954
Total non-current assets
82,746
80,585
Total assets
299,035
298,525
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Trade payables
67,405
67,032
Deferred revenues
2,561
5,507
Short-term loans
28,450
32,600
Operating lease liabilities
3,151
3,889
Other accounts payable and accrued expenses
25,756
23,925
Total current liabilities
127,323
132,953
LONG-TERM LIABILITIES:
Accrued severance pay and pension
8,657
9,399
Deferred revenues
670
670
Operating lease liabilities
13,142
13,716
Other long-term payables
5,742
7,768
Total long-term liabilities
28,211
31,553
SHAREHOLDERS’ EQUITY:
Share capital
224
224
Additional paid-in capital
440,173
437,161
Treasury shares at cost
(20,091)
(20,091)
Other comprehensive loss
(9,853)
(8,087)
Accumulated deficit
(266,952)
(275,188)
Total shareholders’ equity
143,501
134,019
Total liabilities and shareholders’ equity
299,035
298,525
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(U.S. dollars, in thousands)
(Unaudited)
Three months ended
June 30,
Six months ended
June 30,
2024
2023
2024
2023
Cash flow from operating activities:
Net income
7,833
2,088
8,236
4,056
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization
2,941
2,582
5,880
5,135
Loss from sale of property and equipment, net
169
20
169
30
Stock-based compensation expense
1,566
808
2,470
1,977
Decrease in accrued severance pay and
pensions, net
(212)
(280)
(564)
(344)
Increase in trade receivables, net
(16,023)
(6,620)
(9,247)
(6,910)
Decrease (increase) in other assets (including other accounts
receivable, prepaid expenses, other non-current assets, and
the effect of exchange rate changes on cash and cash
equivalents)
(652)
(445)
(1,383)
551
Decrease in inventory
1,186
893
8,555
4,059
Decrease in operating lease right-of-use assets
1,694
886
2,626
1,897
Increase (decrease) in trade payables
12,075
2,835
589
(3,955)
Increase (decrease) in other accounts payable and accrued
expenses (including other long-term payables)
(2,196)
2,620
(94)
2,326
Decrease in operating lease liability
(1,922)
(1,152)
(2,942)
(2,518)
Increase (decrease) in deferred revenues
(1,637)
(1,054)
(2,946)
386
Net cash provided by operating activities
4,822
3,181
11,349
6,690
Cash flow from investing activities:
Purchases of property and equipment, net
(4,562)
(2,330)
(7,955)
(5,472)
Software development costs capitalized
(676)
(549)
(989)
(1,837)
Net cash used in investing activities
(5,238)
(2,879)
(8,944)
(7,309)
Cash flow from financing activities:
Proceeds from exercise of stock options
284
30
542
30
Proceeds from (repayments of) bank credits and loans, net
(2,050)
(2,300)
(4,150)
2,050
Net cash provided by (used in) financing activities
(1,766)
(2,270)
(3,608)
2,080
Effect of exchange rate changes on cash and cash equivalents
(298)
74
(731)
120
Increase (decrease) in cash and cash equivalents
(2,480)
(1,894)
(1,934)
1,581
Cash and cash equivalents at the beginning of the period
28,783
26,423
28,237
22,948
Cash and cash equivalents at the end of the period
26,303
24,529
26,303
24,529
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS
(U.S. dollars in thousands, except share and per share data)
(Unaudited)
Three months ended
June 30,
Six months ended
June 30,
2024
2023
2024
2023
GAAP cost of revenues
62,627
55,795
119,057
111,028
Stock-based compensation expenses
(134)
(48)
(265)
(228)
Amortization of acquired intangible assets
(189)
–
(378)
–
Excess cost on acquired inventory in business combination (*)
–
–
(124)
–
Non-GAAP cost of revenues
62,304
55,747
118,290
110,800
GAAP gross profit
33,461
30,356
65,529
58,532
Stock-based compensation expenses
134
48
265
228
Amortization of acquired intangible assets
189
–
378
–
Excess cost on acquired inventory in business combination (*)
–
–
124
–
Non-GAAP gross profit
33,784
30,404
66,296
58,760
GAAP Research and development expenses
8,385
7,812
17,232
15,750
Stock-based compensation expenses
(184)
(232)
(336)
(478)
Non-GAAP Research and development expenses
8,201
7,580
16,896
15,272
GAAP Sales and marketing expenses
11,508
9,778
22,769
19,974
Stock-based compensation expenses
(387)
(363)
(683)
(739)
Amortization of acquired intangible assets
(117)
–
(388)
–
Non-GAAP Sales and marketing expenses
11,004
9,415
21,698
19,235
GAAP General and administrative expenses
2,295
6,218
8,158
11,542
Stock-based compensation expenses
(861)
(167)
(1,186)
(535)
Non-GAAP General and administrative expenses
1,434
6,051
6,972
11,007
GAAP Restructuring and related charges
–
897
1,416
897
Restructuring and related charges
–
(897)
(1,416)
(897)
Non-GAAP Restructuring and related charges
–
–
–
–
GAAP Acquisition- and integration-related charges
915
–
1,377
–
Acquisition- and integration-related charges
(915)
–
(1,377)
–
Non-GAAP Acquisition- and integration-related charges
–
–
–
–
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS
(U.S. dollars in thousands, except share and per share data)
(Unaudited)
Three months ended
June 30,
Six months ended
June 30,
2024
2023
2024
2023
GAAP Operating income
10,358
5,651
14,577
10,369
Stock-based compensation expenses
1,566
810
2,470
1,980
Amortization of acquired intangible assets
306
–
766
–
Excess cost on acquired inventory in business combination (*)
–
–
124
–
Restructuring and other charges
–
897
1,416
897
Acquisition- and integration-related charges
915
–
1,377
–
Non-GAAP Operating income
13,145
7,358
20,730
13,246
GAAP Financial expenses and others, net
1,916
1,886
4,777
3,344
Leases – financial income
207
285
319
643
Non-cash revaluation associated with business combination
477
–
(196)
–
Non-GAAP Financial expenses and others, net
2,600
2,171
4,900
3,987
GAAP Tax expenses
609
1,677
1,564
2,969
Non cash tax adjustments
–
(890)
(413)
(1,743)
Non-GAAP Tax expenses
609
787
1,151
1,226
GAAP Net income
7,833
2,088
8,236
4,056
Stock-based compensation expenses
1,566
810
2,470
1,980
Amortization of acquired intangible assets
306
–
766
–
Excess cost on acquired inventory in business combination (*)
–
–
124
–
Restructuring and other charges
–
897
1,416
897
Acquisition- and integration-related charges
915
–
1,377
–
Leases – financial income
(207)
(285)
(319)
(643)
Non-cash revaluation associated with business combination
(477)
–
196
–
Non-cash tax adjustments
–
890
413
1,743
Non-GAAP Net income
9,936
4,400
14,679
8,033
GAAP basic net income per share
0.09
0.02
0.10
0.05
GAAP diluted net income per share
0.09
0.02
0.09
0.05
Non-GAAP Diluted net income per share (**)
0.11
0.05
0.17
0.09
(*) Consists of charges to cost of revenues for the difference between the fair value of acquired inventory in business
combination, which was recorded at fair value, and the actual cost of this inventory, which impacts the Company’s gross
profit.
(**) Weighted average number of shares used in computing diluted net income per share is the same as in GAAP
Logo – https://mma.prnewswire.com/media/1704355/Ceragon_Networks_Ltd_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/ceragon-reports-11-5-increase-in-quarterly-revenue-gaap-eps-of-0-09-per-share-in-the-second-quarter-302216487.html
SOURCE Ceragon Networks Ltd.
You may like
Technology
The American Legion seeks entries for Fourth Estate Awards in media
Published
4 seconds agoon
January 9, 2025By
INDIANAPOLIS, Jan. 9, 2025 /PRNewswire/ — The American Legion has announced its call for entries in the annual Fourth Estate Awards competition for excellence in journalism and its positive impact on society. The deadline for submissions to be received or postmarked is March 15, 2025.
The American Legion presents the awards to recognize the outstanding achievements made in print and broadcast media. Website and podcast submissions are also encouraged to compete in the print or broadcast categories. In addition to the award, the winner in each category will be presented a $2,000 stipend to cover travel and lodging expenses to The American Legion National Convention in Tampa. The presentation will occur at approximately 9 am on August 28, 2025 at the Tampa Convention Center.
An entry form with contest rules can be found at https://www.legion.org/information-center/the-fourth-estate-award. You can also contact kchrisman@legion.org for further information.
Submissions are judged on the quality of the work and the impact that it had in producing a positive result for the community. The work must have been published, posted or broadcast in 2024.
All journalists or media outlets who believe their work improved society in a tangible and way are encouraged to submit their entry. There is no entry fee and no single medium is limited to the number of entries.
Past winners include CBS News, CNN, USA Today, WFTS (Tampa) and the Military Times. The complete list can be found at www.legion.org.
Media contacts: Katie Chrisman, (317) 630-1298, kchrisman@legion.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-legion-seeks-entries-for-fourth-estate-awards-in-media-302347119.html
SOURCE The American Legion
Technology
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
Published
7 seconds agoon
January 9, 2025By
ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ — CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited cells for biotech and pharmaceutical applications.
The collaboration application note will be officially unveiled the week of the highly anticipated J.P. Morgan Healthcare Conference in San Francisco this January, a premier event that brings together industry leaders, investors, and innovators from around the world.
“The market has been anticipating a solution that seamlessly integrates non-viral knockout with viral knockin capabilities into a streamlined workflow—one that preserves cell viability and functionality without compromise.” said Dr. Alla Zamarayeva, CEO of CellFE. “By collaborating with Syenex, we are directly addressing this critical need.”
Jay Rosanelli, CEO at Syenex, added: “This joint effort showcases the role of collaborative science in accelerating the creation of life-changing medicines for patients around the globe. We are thrilled to partner with CellFE and showcase the potential of this novel hybrid workflow to dramatically simplify manufacturing of genetic medicines.”
This collaboration comes at a pivotal time as allogeneic and autologous cell therapy providers seek more efficient manufacturing processes. A key challenge is developing gentler yet highly effective techniques for delivering gene-editing cargo to patient cells, as current methods—often involving viral transduction and electroporation—can be detrimental to cells and extend recovery and processing times, particularly for complex, sequential editing. This innovative hybrid workflow aims to overcome these challenges, enabling advanced genetic editing while preserving cell functionality and supporting streamlined workflows.
Both companies will be attending the J.P. Morgan Healthcare Conference this month from January 13-16th. Details on where to partner with the companies at the conference can be found below, along with contact information for both companies.
Partner with CellFE at the JP Morgan Healthcare Conference:
J.P. Morgan Healthcare Conference – Jan 13-16
Westin St. Francis in San Francisco, CABiotech Showcase – Jan 13-15
Hilton Union Square, San Francisco, CABio Partnering at JPMorgan Week – Jan 13-16
San Francisco Marriott Marquis in San Francisco, CA
cellfebiotech.com/meet
Partner with Syenex at the JP Morgan Healthcare Conference:
Bio Partnering at JPMorgan Week – Jan 13-16
San Francisco Marriott Marquis in San Francisco, CA
syenex.com/meet
About CellFE Biotech
CellFE, a cutting-edge microfluidics company, is transforming the development and manufacturing of lifesaving cell therapies to make them more accessible to patients. CellFE aims to unlock the full potential of this transformative modality by tackling its key market challenges, notably high manufacturing costs and extended vein-to-vein timelines. With a focus on T-Cell, HSC, and iPSC-based therapies, CellFE’s microfluidics-based gene-delivery technology, in conjunction with proprietary best-in-class workflows, targets critical bottlenecks in cell therapy manufacturing. For more information, please visit www.cellfebiotech.com.
About Syenex
Syenex builds bioengineering technologies to unlock the future of human health. Leveraging the power of synthetic biology, we design scalable, precision-engineered gene delivery vectors, empowering cell and gene therapy developers to cure disease and build the next generation of medicines. Designed to break the barriers that slow medical progress, our Open Science model ensures global access to our expanding toolkit and a network of scale-up partners, accelerating the path of breakthroughs from idea to impact for all of academia and biopharma. Since 2022, Syenex has rapidly built a portfolio of cell-specific bioengineering systems and established partnerships across the fields of immune cell, stem cell, and hepatocyte engineering. Learn more and get started at www.syenex.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cellfe-and-syenex-collaborate-to-advance-cell-engineering-with-hybrid-gene-editing-workflow-302347122.html
SOURCE CellFE
Technology
The TreppWire Podcast Celebrates 300th Episode with Strategic Rebrand and Enhanced Vision
Published
9 seconds agoon
January 9, 2025By
Trepp announced today a rebrand and enhanced vision for The TreppWire Podcast ahead of its milestone 300th episode.
NEW YORK, Jan. 9, 2025 /PRNewswire-PRWeb/ — Trepp, a leading provider of data, insights, and technology solutions to the structured finance, commercial real estate (CRE), and banking markets announced today a rebrand and enhanced vision for The TreppWire Podcast ahead of its milestone 300th episode.
Since its launch in 2020, The TreppWire Podcast has garnered more than 1.7 million listens, establishing itself as a leading voice in the CRE industry, as well as the structured finance, banking, and broader economic markets. The podcast leverages Trepp’s proprietary commercial property, loan, and financial data and deep market expertise to provide weekly insights to industry professionals.
Complemented by a sleek new visual identity and modern design aesthetic, this strategic rebrand builds upon Trepp’s 40-year legacy of delivering timely, accurate, and comprehensive specialized CRE data and insights to help listeners make better, more informed decisions. Through market cycles, volatility, and periods of growth, The TreppWire Podcast remains committed to uncovering both challenges and opportunities, providing listeners with actionable insights to navigate market dynamics.
The rebrand also introduces an elevated format, which will include frequent industry expert guest appearances, as well as exclusive macroeconomic commentary from Trepp’s newly appointed Chief Economist, Rachel Szymanski. The podcast will continue to be a go-to resource for market participants, delivering timely insights from diverse industry perspectives.
“It is so exciting to watch our podcast hit the 300th episode milestone. Powered by our marketing, research, and product groups, this show has been a trusted resource for the commercial real estate community, and we are excited to continue its growth,” said Hayley Keen, VP, Head of Marketing. “The market has trusted Trepp’s data for more than 40 years, and with this rebrand, we’re not just maintaining that commitment – we’re elevating it. We’re enhancing the podcast experience while staying true to what our audience has always trusted us for: delivering reliable, actionable market intelligence that helps them make informed, confident decisions.”
Listeners can tune in to the newly rebranded The TreppWire Podcast on all major podcast platforms, including Apple Podcasts, Spotify, SoundCloud, and YouTube. Weekly episodes are released every Thursday. Check out our new website to learn more: https://www.trepp.com/the-treppwire-podcast
About Trepp
Trepp, founded in 1979, is the leading provider of data, insights, and technology solutions to the structured finance, commercial real estate, and banking markets. Trepp provides primary and secondary market participants with the solutions and analytics they need to increase operational efficiencies, information transparency, and investment performance. From its offices in New York, Dallas, and London, Trepp serves its clients with products and services to support trading, research, risk management, surveillance, and portfolio management. Trepp subsidiary, Commercial Real Estate Direct, is a daily news source covering the commercial real estate capital markets. Trepp is owned by the Daily Mail and General Trust (DMGT)
Media Contact
Ennys Soydas, Trepp, Inc., 212-754-1010, press@trepp.com, www.trepp.com
View original content to download multimedia:https://www.prweb.com/releases/the-treppwire-podcast-celebrates-300th-episode-with-strategic-rebrand-and-enhanced-vision-302346930.html
SOURCE Trepp, Inc.
The American Legion seeks entries for Fourth Estate Awards in media
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
The TreppWire Podcast Celebrates 300th Episode with Strategic Rebrand and Enhanced Vision
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days ago
WHAT NOT TO MISS AT CES 2025
-
Technology5 days ago
Sustainable Energy Brand EBL to Unveil Energy Solutions for Home, Office, and Outdoor at CES 2025
-
Technology5 days ago
SHOWCASING TOMORROW’S INNOVATORS: LG NOVA RETURNS TO CES 2025
-
Coin Market5 days ago
$19 trillion in transactions settled on the Bitcoin network in 2024
-
Coin Market5 days ago
BTC exchange inflow and miner outflow drop — BTC to reclaim $100K?
-
Technology4 days ago
BE OPEN Art launches the first regional competition of 2025 to support emerging artists of South Asia
-
Technology5 days ago
TESSAN and Rachael Yamagata Unveil a Musical Journey: Discover the World Through Song and Story
-
Coin Market5 days ago
Elon Musk announces change to X algorithm, faces backlash